The role of extended treatment discussed by mastitis experts
‘The benefit of extended therapy for mastitis, myth or fact?’ was the topic at the third global milk quality expert forum,
Read More‘The benefit of extended therapy for mastitis, myth or fact?’ was the topic at the third global milk quality expert forum,
Read MoreAs part of the Ubrocare program for the mastitis prevention and treatment, Boehringer Ingelheim has recently launched Ubrocare.com. This is an innovative multidevice website through which you will be able to become an expert in mastitis! This content is for M²-DIGITAL, M²-PREMIUM, M²-INSTITUTIONAL & NMC members only. Log in ifRead more
Read MoreTrends in herd udder health and risk factors can be identified by monitoring the trends of individual cow cell counts. Useful parameters are the proportion of infected cows and heifers at their first post-calving somatic cell count (SCC) check and the cell count evolution over the dry period. This contentRead more
Read MoreBoehringer Ingelheim’s second Quality Milk Expert Forum entitled ‘What is the future of dry cow therapy?’
Read MoreBoehringer Ingelheim is very proud to be one of the major sponsors of the first National Mastitis Council (NMC) meeting to be held in Europe, where it will present two posters on Ubrolexin®.
Read More